十二五重大专项“贝达喹啉血药浓度监测对中国耐多药肺结核患者的临床意义”——谢莉

北京市卫生健康委员会科教处，首都卫生发展科研专项，自主创新项目，首发2020-2-2162，贝达喹啉血药浓度监测对中国耐多药肺结核患者的临床意义，2020-1至2022-12，22.944万元在研主持。

(1) Mengqiu Gao#; Jingtao Gao#; Li Xie#; GuihuiWu;WeiChen;YuChen;Yi Pei ;Guobao Li; Yuhong Liu; Wei Shu; Lin Fan; Qianhong Wu; Juan Du; Xiaohong Chen;Pejun Tang; Yu Xiong; Mingwu Li; Qingshan Cai; Long Jin; Zaoxian Mei; Yu Pang*;Liang Li*;Early outcome and safety of bedaquiline-containing regimens for treatment of MDR-and XDR-TB in china: a multicentre study. Clin Microbiol Infect, 2020 Jun 15;S1198-743X(20)30344-X.

(2) 谢莉#；杜凤娇；杨新婷；李华；贾红彦；邢爱英；杜博平；孙琦；张宗德；高孟秋*；全血g-干扰素释放试验对活动性结核病的辅助诊断价值研究，国际呼吸杂志 2018，38（ 3） 169-172

(3) Fengjiao Du#；Li Xie#；Yonghong Zhang； Fei Gao；Huibin Zhang； Wei Chen；Bingqi Sun；Wei Sha；Yong Fang；Hongyan Jia；Aiying Xing；Boping Du； Li Zheng；Mengqiu Gao*；Zongde Zhang*；Prospective comparison of QFT-GIT and T-SPOT.TB  assays for diagnosis of active tuberculosis. Scientific Reports. 2018，4:5882